Skip to main content
NTHI
NASDAQ Life Sciences

NeOnc Technologies Finalizes $1.45M Private Placement at Significant Discount

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$9.18
Mkt Cap
$208.314M
52W Low
$3.2
52W High
$25
52W Position info
187% above low
Off High info
63% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NTHI has more than doubled off its 52-week low of $3.2.

Summary

NeOnc Technologies Holdings, Inc. completed a $1.45 million private placement of common stock and warrants at a substantial discount to the current market price, with proceeds for working capital.


Key Events · Financing and Capital Events · NTHI

  • Private Placement Closing

    The company completed a closing of a Securities Purchase Agreement, issuing 201,390 shares of common stock and warrants to purchase an equal number of shares for an aggregate purchase price of $1,450,004.

  • Discounted Pricing

    The shares were sold at $7.20 per share, representing a significant discount of approximately 21.5% compared to the current stock price of $9.18. Warrants are exercisable at $9.00 per share.

  • Use of Proceeds

    The net proceeds from this offering are intended for general working capital purposes.

  • Resale Registration Commitment

    The company will file a resale registration statement for the issued shares and warrant shares no later than ten days after filing its Annual Report on Form 10-K for the year ended December 31, 2025.


Analysis · NTHI · Life Sciences

This 8-K details the final closing of a private placement, where NeOnc Technologies Holdings, Inc. issued 201,390 shares and warrants for an aggregate of $1.45 million. The shares were sold at $7.20, representing a significant discount of approximately 21.5% compared to the current stock price of $9.18. While the capital raise provides funds for working capital, the deep discount at which the securities were issued indicates a potentially challenging financing environment or urgency for capital, leading to substantial dilution for existing shareholders. The company also committed to filing a resale registration statement for these securities. This filing confirms and provides official details for a private placement previously reported in news.

How filings like this one have moved

In the 30 days to Oct 31, 2026, 39.9% of the 977 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NTHI was trading at $9.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $208.3M. The 52-week trading range was $3.20 to $25.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NTHI - Latest Insights

NTHI
Sep 28, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.16
Real-time Price: $3.12 info
Change: -$0.040 (-1%) info
Market Cap: $93.906M info
NTHI
Sep 15, 2026, 8:47 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $3.31
Real-time Price: $3.12 info
Change: -$0.190 (-6%) info
Market Cap: $93.906M info
NTHI
Sep 10, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.72
Real-time Price: $3.12 info
Change: -$0.595 (-16%) info
Market Cap: $93.906M info
NTHI
Sep 10, 2026, 10:25 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $3.73
Real-time Price: $3.12 info
Change: -$0.605 (-16%) info
Market Cap: $93.906M info
NTHI
Sep 09, 2026, 12:43 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.60
Real-time Price: $3.12 info
Change: -$0.480 (-13%) info
Market Cap: $93.906M info